The FDA has offered positive feedback on possible paths forward for accelerated or traditional approval of FLT201 using data from a single-arm study.

ONAPGOis the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in adults with advanced Parkinson’s ...

In a Phase IIb trial, GH001 elicited significant drops in treatment-resistant depression. The news comes less than two weeks ...

Warszawa (2) Wojskowy Instytut Medyczny,Państwowy Instytut Badawczy Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie ...

The upcoming Phase 1/2 clinical trial, dubbed RESET-MS, will enroll adults, ages 18-60, who have either relapsing or progressive forms of MS. To be eligible, patients with relapsing MS must have ...

At seven-years follow up, invasive disease-free survival was 80.8% with adjuvant T-DM1 and 67.1% with adjuvant trastuzumab alone. Overall survival was 89.1% with T-DM1 and 84.4% with trastuzumab ...

Israel believes the bodies of dead hostages will also likely be among 33 people released during the first phase of the deal. Quoting q diplomat close to the negotiations, CNN reported that a final ...

NEW YORK--(BUSINESS WIRE)--Signet Therapeutics (“Signet”), a clinical-stage biotech company leveraging organoids and AI to develop first-in-class cancer therapies, today announced that the first ...

Historically, I’m willing to say with some caution that this is the last phase of Zionism. Historically, such developments in ideological movements, whether they are colonials or empires ...

Phase 1 will probably open up the faction specific offensive events in Pandaria, as well as mark the start of Wrathion’s quest that eventually rewards players with a Legendary Cloak. Throne of Thunder ...

The Big Pharma is handing China’s Simcere Zaiming an undisclosed upfront payment with the potential of up to $1.05 billion in milestone payments for a phase 1-stage trispecific antibody.

Pfizer’s phase 3 trial assessed the effect of giving a PD-1 inhibitor, sasanlimab, in combination with BCG as a first-line treatment. All patients in the two arms included in the primary ...